Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapyBreast Cancer Res Treat 2022 Sep 07;[EPub Ahead of Print], SY Park, KJ Suh, DW Lee, HS Ryu, M Kim, SH Kim, KH Lee, TY Kim, JH Kim, IA Park, SA Im
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.